Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. P.A. (Paul) van der Zwaag

Publicaties

Age-related penetrance of phospholamban p.Arg14del cardiomyopathy

Multigene panel analysis has limited additional value compared to transthyretin gene analysis in Dutch patients with suspected cardiac amyloidosis

Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?: an early follow-up marker?

ECG-only Explainable Deep Learning Algorithm Predicts the Risk for Malignant Ventricular Arrhythmia in Phospholamban Cardiomyopathy

High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients

Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

[99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy

Pers/media

Kwart miljoen opgehaald voor onderzoek naar Friese ziekte: 'Het ontwricht hele families'

Gaspedaal van het hart